JointHealth™ express   June 26, 2019

JointHealth™ insight – May/June 2019

Biosimilars: The next generation of biologic treatment for inflammatory arthritis patients

In this issue of JointHealth™ insight, we provide patients with inflammatory arthritis important facts to help them understand biosimilars and have an informed conversation with their healthcare provider.

Topics covered in this issue include:
  • British Columbia’s new ‘Biosimilar Initiative’ and what it means for patients
  • The science behind biosimilars
  • The definition of transitioning and Health Canada’s statement on biosimilar transitioning
  • Patient experiences with transitioning in Europe and in Canada
  • ACE’s new Biosimilars in Canada Guide- What Inflammatory Arthritis Patients Need to Know
  • Societal benefits of biosimilars